GH Research (GHRS) News Today $13.98 -0.01 (-0.04%) Closing price 02/20/2025 03:59 PM EasternExtended Trading$14.00 +0.02 (+0.14%) As of 02/20/2025 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Cantor Fitzgerald Forecasts GH Research FY2024 EarningsGH Research PLC (NASDAQ:GHRS - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2024 EPS estimates for shares of GH Research in a report released on Thursday, February 13th. Cantor Fitzgerald analyst C. Duncan forecasts that the company will post earnings of ($0.79) per sharFebruary 17, 2025 | marketbeat.comGH Research initiated with an Overweight at Cantor FitzgeraldFebruary 14, 2025 | markets.businessinsider.comCantor Fitzgerald Initiates Coverage of GH Research (GHRS) with Overweight RecommendationFebruary 14, 2025 | msn.comCantor Fitzgerald sets GH Research stock Overweight, $14 targetFebruary 13, 2025 | msn.comGH Research (NASDAQ:GHRS) Coverage Initiated at Cantor FitzgeraldCantor Fitzgerald began coverage on GH Research in a report on Thursday. They issued an "overweight" rating and a $14.00 price target for the company.February 13, 2025 | marketbeat.comFMR LLC Reduces Stake in GH Research PLC: Analyzing the Strategic MoveFebruary 12, 2025 | gurufocus.comLynx1 Capital Management LP Increases Stake in GH Research PLCFebruary 10, 2025 | gurufocus.comLynx1 Capital Management LP Increases Stake in GH Research PLCFebruary 10, 2025 | gurufocus.comGH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last weekFebruary 9, 2025 | finance.yahoo.comGH Research (NASDAQ:GHRS) Shares Down 7.6% - What's Next?GH Research (NASDAQ:GHRS) Stock Price Down 7.6% - Here's WhyFebruary 6, 2025 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Gap Up - Here's WhyGH Research (NASDAQ:GHRS) Shares Gap Up - Here's What HappenedFebruary 6, 2025 | marketbeat.comGH Research stock hits 52-week high at $19.98 amid growthFebruary 5, 2025 | msn.comGH Research (NASDAQ:GHRS) Shares Gap Down - What's Next?GH Research (NASDAQ:GHRS) Shares Gap Down - Time to Sell?February 5, 2025 | marketbeat.comGH Research Shares Jump After Positive Phase 2B Trial ResultsFebruary 5, 2025 | marketwatch.comGH Research 10M share Secondary priced at $15.00February 5, 2025 | markets.businessinsider.comGH Research (NASDAQ:GHRS) Reaches New 12-Month High - Should You Buy?GH Research (NASDAQ:GHRS) Hits New 52-Week High - Here's What HappenedFebruary 5, 2025 | marketbeat.comGH Research Announces Pricing of $150 Million Public OfferingFebruary 4, 2025 | globenewswire.comGH Research (NASDAQ:GHRS) Shares Gap Up - Should You Buy?GH Research (NASDAQ:GHRS) Shares Gap Up - Should You Buy?February 4, 2025 | marketbeat.comGH Research announces $150M ordinary shares offeringFebruary 4, 2025 | markets.businessinsider.comJMP Securities Reaffirms Their Buy Rating on GH Research (GHRS)February 4, 2025 | markets.businessinsider.comH.C. Wainwright maintains buy on GH Research stock, $40 targetFebruary 4, 2025 | msn.comGH Research Announces Proposed Public OfferingFebruary 3, 2025 | globenewswire.comGH Research (NASDAQ:GHRS) Hits New 1-Year High - Still a Buy?GH Research (NASDAQ:GHRS) Hits New 1-Year High - Time to Buy?February 3, 2025 | marketbeat.comGH Research’s GH001 Shows Promising Results in TRD Phase 2b TrialFebruary 3, 2025 | tipranks.comGH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS ReductionFebruary 3, 2025 | globenewswire.comGH Research to Provide Update on Phase 2b Trial with GH001 in TRDJanuary 31, 2025 | globenewswire.comAnalysts Offer Predictions for GH Research FY2024 EarningsGH Research PLC (NASDAQ:GHRS - Free Report) - HC Wainwright lowered their FY2024 earnings estimates for shares of GH Research in a note issued to investors on Monday, January 27th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of ($0.80) for the yJanuary 29, 2025 | marketbeat.comAnalysts Set Expectations for GH Research FY2029 EarningsGH Research PLC (NASDAQ:GHRS - Free Report) - Stock analysts at HC Wainwright issued their FY2029 EPS estimates for shares of GH Research in a report issued on Monday, January 27th. HC Wainwright analyst P. Trucchio forecasts that the company will post earnings per share of $0.10 for the year. HCJanuary 28, 2025 | marketbeat.comPromising Outlook for GH Research: Buy Rating Driven by GH001’s Progress and Market PotentialJanuary 27, 2025 | markets.businessinsider.comH.C. Wainwright maintains $40 target on GH Research stockJanuary 27, 2025 | msn.comGH Research's (GHRS) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of GH Research in a report on Monday.January 27, 2025 | marketbeat.comGH Research PLC (NASDAQ:GHRS) Sees Large Increase in Short InterestGH Research PLC (NASDAQ:GHRS - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 2,280,000 shares, a growth of 11.8% from the December 15th total of 2,040,000 shares. Based on an average daily volume of 72,900 shares, the short-interest ratio is presently 31.3 days. Approximately 7.5% of the company's shares are short sold.January 18, 2025 | marketbeat.comOptimistic Outlook for GH Research: Promising Phase 2a Results and Favorable Safety ProfileJanuary 11, 2025 | markets.businessinsider.comGH Research (NASDAQ:GHRS) Given Buy Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $40.00 price objective on shares of GH Research in a research report on Friday.January 10, 2025 | marketbeat.comGH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-RodentsJanuary 10, 2025 | globenewswire.comGH Research (NASDAQ:GHRS) Trading Down 6.7% - Should You Sell?GH Research (NASDAQ:GHRS) Trading Down 6.7% - Should You Sell?January 2, 2025 | marketbeat.comFmr LLC Has $18.37 Million Position in GH Research PLC (NASDAQ:GHRS)Fmr LLC lowered its holdings in shares of GH Research PLC (NASDAQ:GHRS - Free Report) by 7.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,745,445 shares of the company's stock after sellingDecember 11, 2024 | marketbeat.comGH Research PLC (NASDAQ:GHRS) Shares Purchased by RA Capital Management L.P.RA Capital Management L.P. lifted its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 1.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,686,689 shares of the company's stock after purchasingDecember 5, 2024 | marketbeat.comVerition Fund Management LLC Reduces Position in GH Research PLC (NASDAQ:GHRS)Verition Fund Management LLC cut its stake in shares of GH Research PLC (NASDAQ:GHRS - Free Report) by 7.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,057,782 shares of the company's stock after sellingDecember 2, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Down 0.3% - Here's WhyGH Research (NASDAQ:GHRS) Shares Down 0.3% - Should You Sell?November 29, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 2% - Should You Buy?GH Research (NASDAQ:GHRS) Trading 2% Higher - Time to Buy?November 28, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 0.8% - Here's What HappenedGH Research (NASDAQ:GHRS) Stock Price Down 0.8% - Here's WhyNovember 27, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 1.4% - Here's WhyGH Research (NASDAQ:GHRS) Trading Up 1.4% - What's Next?November 25, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Down 5.1% - What's Next?GH Research (NASDAQ:GHRS) Shares Down 5.1% - What's Next?November 22, 2024 | marketbeat.comBrokers Offer Predictions for GH Research FY2024 EarningsGH Research PLC (NASDAQ:GHRS - Free Report) - Equities researchers at HC Wainwright cut their FY2024 EPS estimates for shares of GH Research in a research note issued to investors on Tuesday, November 19th. HC Wainwright analyst P. Trucchio now forecasts that the company will earn ($0.76) per shaNovember 22, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 1.7% - Here's What HappenedGH Research (NASDAQ:GHRS) Stock Price Down 1.7% - Here's What HappenedNovember 21, 2024 | marketbeat.comPromising Advancements in GH Research’s Clinical Trials Boost Buy RatingNovember 21, 2024 | markets.businessinsider.comGH Research Q3 2024 Results and Clinical UpdatesNovember 21, 2024 | markets.businessinsider.comGH Research (NASDAQ:GHRS) Trading Up 2% - Time to Buy?GH Research (NASDAQ:GHRS) Stock Price Up 2% - What's Next?November 20, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading 1.2% Higher - Time to Buy?GH Research (NASDAQ:GHRS) Trading 1.2% Higher - Time to Buy?November 19, 2024 | marketbeat.com Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address GHRS Media Mentions By Week GHRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GHRS News Sentiment▼0.510.60▲Average Medical News Sentiment GHRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GHRS Articles This Week▼62▲GHRS Articles Average Week Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Xenon Pharmaceuticals News MorphoSys News Twist Bioscience News Vericel News Catalyst Pharmaceuticals News MoonLake Immunotherapeutics News Merus News Beam Therapeutics News ImmunityBio News Arrowhead Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GHRS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GHRS Stock Alerts